(Q36473426)

14 August 2017

1 reference

title

Nitric oxide and atherosclerosis: an update (English)

1 reference

14 August 2017

1 reference

6

Louis J Ignarro

1 reference

14 August 2017

2

Filomena de Nigris

1 reference

14 August 2017

1

Claudio Napoli

1 reference

14 August 2017

Sharon Williams-Ignarro

series ordinal

3

object named as

Sharon Williams-Ignarro

1 reference

14 August 2017

Orlando Pignalosa

4

1 reference

14 August 2017

Vincenzo Sica

series ordinal

5

1 reference

14 August 2017

publication date

15 April 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

15

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

265-279

1 reference

Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis

14 August 2017

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Enhanced vasoconstrictor responses in eNOS deficient mice.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Distribution and prevalence of inducible nitric oxide synthase in atherosclerotic vessels of long-term cholesterol-fed rabbits

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

A polymorphism of the endothelial nitric oxide synthase promoter is associated with an increase in autonomic imbalance in patients with congestive heart failure

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh Artery Study

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Regulation of inducible nitric oxide synthase expression in advanced glycation end product-stimulated raw 264.7 cells: the role of heme oxygenase-1 and endogenous nitric oxide

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Endothelium-derived relaxing factor: discovery, early studies, and identification as nitric oxide.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

eNOS G894T polymorphism as a mild predisposing factor for abdominal aortic aneurysm

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Nitric oxide stimulated vascular smooth muscle cells undergo apoptosis induced in part by arachidonic acid derived eicosanoids

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

The oxidation hypothesis of atherosclerosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Does ADMA cause endothelial dysfunction?

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein e/endothelial nitric oxide synthase double knockout mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Endogenous nitric oxide in cardiovascular disease and transplantation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Peroxynitrite-mediated oxidative protein modifications

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Peroxisome proliferator-activated receptor-alpha and atherosclerosis: from basic mechanisms to clinical implications

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Effect of acetylcholine on the highly stenotic coronary artery: difference between the constrictor response of the infarct-related coronary artery and that of the noninfarct-related artery

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Biological significance of endogenous methylarginines that inhibit nitric oxide synthases

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Influence of eNOS Gene Polymorphisms on Carotid Atherosclerosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Nitric oxide as a signaling molecule in the vascular system: an overview.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Involvement of oxidation-sensitive mechanisms in the cardiovascular effects of hypercholesterolemia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Nitric oxide and atherosclerosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Gene transfer of endothelial NO synthase, but not eNOS plus inducible NOS, regressed atherosclerosis in rabbits

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Glycoxidized low-density lipoprotein downregulates endothelial nitricoxide synthase in human coronary cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Vasomotor effects of L- and D-arginine in stenotic atheromatous coronary plaque

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

The physiological role and pharmacological potential of nitric oxide in neutrophil activation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Hypercholesterolemia and hypertension have synergistic deleterious effects on coronary endothelial function

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Statin treatment and the natural history of atherosclerotic-related diseases: pathogenic mechanisms and the risk-benefit profile.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

L-arginine ameliorates the abnormal sympathetic response of the dysfunctional human coronary microvasculature

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

An integrated evaluation of endothelial constitutive nitric oxide synthase polymorphisms and coronary artery disease in men.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Mildly Oxidized Low-Density Lipoprotein Impairs Responses of Carotid but Not Basilar Artery in Rabbits

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Genetic polymorphisms G894T on the eNOS gene is associated with endothelial function and vWF levels in premature myocardial infarction survivors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Nitric oxide-releasing drugs

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Paradoxical reduction of fatty streak formation in mice lacking endothelial nitric oxide synthase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Relationship between the G894T polymorphism (Glu298Asp variant) in endothelial nitric oxide synthase and nitric oxide-mediated endothelial function in human atherosclerosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Nitric oxide (NO)-releasing statin derivatives, a class of drugs showing enhanced antiproliferative and antiinflammatory properties

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Antioxidant intervention blunts renal injury in experimental renovascular disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

L-arginine attenuates lymphocyte activation and anti-oxidized LDL antibody levels in patients undergoing angioplasty

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Low density lipoprotein oxidation and its pathobiological significance

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-indepen

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Does nitric oxide modulate mitochondrial energy generation and apoptosis?

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Atherosclerosis — An Inflammatory Disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Endothelial nitric oxide synthase gene polymorphism and ischemic heart disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Induction of nitric oxide synthase in the neointima induced by a periarterial collar in rabbits

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

A common variant of the endothelial nitric oxide synthase (Glu298-->Asp) is a major risk factor for coronary artery disease in the UK

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Endothelial nitric oxide synthase protects aortic allografts from the development of transplant arteriosclerosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Beneficial effects of antioxidants and L-arginine on oxidation-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) in patients with coexistent hypertrophic cardiomyopathy and coronary spastic angina

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Ex vivo gene transfer of endothelial nitric oxide synthase to atherosclerotic rabbit aortic rings improves relaxations to acetylcholine

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Coronary stenosis dilatation induced by L-arginine

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Regression of atherosclerosis: role of nitric oxide and apoptosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Role of oxidative stress in atherosclerosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Atherosclerosis and the two faces of endothelial nitric oxide synthase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Atherogenesis and the arginine hypothesis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Nitric oxide and other novel therapies for pulmonary hypertension

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Short-term triglyceride lowering with fenofibrate improves vasodilator function in subjects with hypertriglyceridemia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Endothelial function and carotid intima-media thickness in young healthy subjects among endothelial nitric oxide synthase Glu298-->Asp and T-786-->C polymorphisms

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Role of endothelium in ischemic coronary syndromes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Clinical and inflammatory effects of dietary L-arginine in patients with intractable angina pectoris

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Effects of changing the availability of the substrate for nitric oxide synthase by L-arginine administration on coronary vasomotor tone in angina patients with angiographically narrowed and in patients with normal coronary arteries

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

The role of apoptosis in vascular disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Effect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Basal and flow-mediated nitric oxide production by atheromatous coronary arteries

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Asymmetrical dimethylarginine: the Uber marker?

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Expression of inducible nitric oxide synthase in macrophages and smooth muscle cells in various types of human atherosclerotic lesions

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

High CA repeat numbers in intron 13 of the endothelial nitric oxide synthase gene and increased risk of coronary artery disease.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Oral L-arginine in patients with coronary artery disease on medical management

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Oxidation of LDL, atherogenesis, and apoptosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Effect of hypercholesterolemia on vascular reactivity in the rabbit. II. Influence of treatment with dipyridamole on endothelium-dependent and endothelium-independent responses in isolated aortas of control and hypercholesterolemic rabbits

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Apoptosis: basic mechanisms and implications for cardiovascular disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Expression of Interleukin-10 in Advanced Human Atherosclerotic Plaques

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Regulation of platelet granule exocytosis by S-nitrosylation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

New trends in anti-atherosclerotic agents.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Nitric oxide and coronary endothelial dysfunction in humans

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Vasoreactivity of the culprit lesion in unstable angina

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Expression of inducible nitric oxide synthase in T lymphocytes and macrophages of cholesterol-fed rabbits

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Multiple role of reactive oxygen species in the arterial wall.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Effect of L-arginine administration on myocardial thallium-201 perfusion during exercise in patients with angina pectoris and normal coronary angiograms

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production : key role of L-arginine availability

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Inactivation of endothelial derived relaxing factor by oxidized lipoproteins

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

A calcium channel blocker activates both ecto-5′-nucleotidase and NO synthase in HUVEC

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Microarray analysis: a novel research tool for cardiovascular scientists and physicians.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NIOX.2006.03.011

Identifiers

DOI

10.1016/J.NIOX.2006.03.011

1 reference

14 August 2017

1 reference